Below you'll find a list of all posts that have been tagged as “cannabinoids”
David Traylor is Senior Managing Director at Golden Eagle Partners, and organizer of the CannMed 24 Capital Markets Workshop. After advising on various transactions in the life science sector, David took an interest in the cannabis sector and started advising cannabis companies before eventually re-foundeding Golden Eagle Partners in 2014 to focus on advising companies across the cannabis sector. Before …
Arnaud Dumas de Rauly is the co-founder and CEO of The Blinc Group, a company that is transforming the cannabis vaping industry with its focus on safety, innovation, and quality. As a leading expert in the science, technology, and supply chain of cannabis vaping merchandise, Arnaud’s assistance and expertise in the vaping sector have been requested by multiple regulatory bodies …
David Traylor is Senior Managing Director at Golden Eagle Partners, a firm he originally founded in to advise life science companies. After advising on various transactions in the life science sector, he took an interest in the cannabis sector and started advising cannabis companies before eventually re-founding Golden Eagle Partners in 2014 to focus on advising companies across the cannabis …
Dedi Meiri, PhD runs a lab at the Technion Israel Institute of Technology that investigates the anti-tumor effects of cannabinoids. More specifically, his team identifies which combination of cannabinoids can kill cancer cells. Most notably, his team identified three specific cannabinoids that kill leukemia cells and that formulation is currently being tested in a clinical trial in Israel. Dr. Meiri …
